Brief resolved unexplained event: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | == Background == | ||
* | *Peak incidence: 1wk - 2mo | ||
* | *ALTE is a symptom, not a dx | ||
** | *Only 10% have repeat events | ||
*ALTE is not related to SIDS | |||
=== | == Diagnosis == | ||
*Episode that is frightening to caregiver and involves combination of: | |||
**Apnea | |||
**Color change | |||
**Muscle tone change | |||
**Choking or gagging | |||
== | ==History== | ||
*PMH | |||
**Prematurity, history of apnea, prior resp/feeding difficulties | |||
**Immunization status (pertussis) | |||
*FH | |||
**History of SIDS, cardiac, seizure, metabolic disease | |||
*Event | |||
**Duration, resus required | |||
**Temporal relationship with feeding, sleeping, crying, vomiting, choking | |||
**Central versus obstructive pattern of apnea | |||
**Episodic versus sustained change in mental status | |||
*ROS | |||
**Respiratory symptoms | |||
**Medication use | |||
=== | == Risk Factors == | ||
#RSV infection | |||
#Prematurity | |||
#Recent anesthesia | |||
# | #GERD | ||
# | #Airway/maxillofacial anomalies | ||
# | |||
# | |||
# | |||
== | == DDX == | ||
Common | |||
#Idiopathic (~50%) | |||
# | #GERD | ||
# | #Seizure | ||
# | #Respiratory tract infection | ||
# | #Misinterpretation of benign process (e.g. periodic breathing) | ||
# | #Vomiting/choking episode | ||
Less common | |||
#Pertussis | |||
# | #Inflicted injury | ||
# | #Poisoning | ||
# | #Serious bacterial infection | ||
##Must consider in all febrile pts with ALTE | |||
#Electrolyte abnormality (incl glucose) | |||
Uncommon | |||
#Arrhythmia | |||
# | #Anemia | ||
#Breath-holding spell (6mo - 4yrs) | |||
#Metabolic disease | |||
#Metabolic | |||
== | == Work-Up == | ||
#UA | |||
#CBC | |||
#Chem | |||
#?CXR | |||
#?EKG | |||
== | == Management == | ||
#Stable patients with a clear diagnosis | |||
##Manage according to identified disease | |||
#Unstable patients without a clear diagnosis | |||
[[Category:Peds]] | {| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%" | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Medication/Intervention | |||
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Indication | |||
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Dose/Size (for neonate) | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Glucose | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypoglycemia | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 5–10 mL/kg of 10% dextrose in water IV | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 3% normal saline | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Symptomatic hyponatremia | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 3–5 mL/kg bolus IV | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Calcium | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypocalcemia | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50–100 milligrams/kg calcium gluconate or 20 milligrams/kg calcium chloride IV | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Cefotaxime | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Infection | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50 milligrams/kg IV | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Ampicillin | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Infection | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50 milligrams/kg IV | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Packed red blood cells | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Anemia | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 10 mL/kg IV | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Normal saline | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypotension, dehydration | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 20 mL/kg IV | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 10% dextrose in one fourth normal saline | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Metabolic disease | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 1.5 maintenance (6 mL/kg/h for the first 10 kg) | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Endotracheal intubation | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypoventilation or frequent apnea | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | <span class="Apple-style-span" style="font-size: 12px; ">3mm for preemie; 3mm for term neonate, 4mm</span><span class="Apple-style-span" style="font-size: 10px;"> </span>for older infant | |||
|} | |||
#Stable patients without a clear diagnosis | |||
##No evidence-based guidelines for proper w/u / dispo decision | |||
== Disposition == | |||
Consider admission for: | |||
#<48wk postconceptual age | |||
#Ill-appearing | |||
#Bronchiolitis or pertussis w/ apnea | |||
#>1 event in past 24hr or multiple ALTEs | |||
#Abnormalities in PMH | |||
#Prolonged central apnea >20s | |||
#ALTE requiring resus | |||
#Family history of SIDS | |||
== Source == | |||
Tintinalli | |||
<br/>[[Category:Peds]] <br/><br/> | |||
Revision as of 00:28, 14 June 2011
Background
- Peak incidence: 1wk - 2mo
- ALTE is a symptom, not a dx
- Only 10% have repeat events
- ALTE is not related to SIDS
Diagnosis
- Episode that is frightening to caregiver and involves combination of:
- Apnea
- Color change
- Muscle tone change
- Choking or gagging
History
- PMH
- Prematurity, history of apnea, prior resp/feeding difficulties
- Immunization status (pertussis)
- FH
- History of SIDS, cardiac, seizure, metabolic disease
- Event
- Duration, resus required
- Temporal relationship with feeding, sleeping, crying, vomiting, choking
- Central versus obstructive pattern of apnea
- Episodic versus sustained change in mental status
- ROS
- Respiratory symptoms
- Medication use
Risk Factors
- RSV infection
- Prematurity
- Recent anesthesia
- GERD
- Airway/maxillofacial anomalies
DDX
Common
- Idiopathic (~50%)
- GERD
- Seizure
- Respiratory tract infection
- Misinterpretation of benign process (e.g. periodic breathing)
- Vomiting/choking episode
Less common
- Pertussis
- Inflicted injury
- Poisoning
- Serious bacterial infection
- Must consider in all febrile pts with ALTE
- Electrolyte abnormality (incl glucose)
Uncommon
- Arrhythmia
- Anemia
- Breath-holding spell (6mo - 4yrs)
- Metabolic disease
Work-Up
- UA
- CBC
- Chem
- ?CXR
- ?EKG
Management
- Stable patients with a clear diagnosis
- Manage according to identified disease
- Unstable patients without a clear diagnosis
| Medication/Intervention | Indication | Dose/Size (for neonate) |
|---|---|---|
| Glucose | Hypoglycemia | 5–10 mL/kg of 10% dextrose in water IV |
| 3% normal saline | Symptomatic hyponatremia | 3–5 mL/kg bolus IV |
| Calcium | Hypocalcemia | 50–100 milligrams/kg calcium gluconate or 20 milligrams/kg calcium chloride IV |
| Cefotaxime | Infection | 50 milligrams/kg IV |
| Ampicillin | Infection | 50 milligrams/kg IV |
| Packed red blood cells | Anemia | 10 mL/kg IV |
| Normal saline | Hypotension, dehydration | 20 mL/kg IV |
| 10% dextrose in one fourth normal saline | Metabolic disease | 1.5 maintenance (6 mL/kg/h for the first 10 kg) |
| Endotracheal intubation | Hypoventilation or frequent apnea | 3mm for preemie; 3mm for term neonate, 4mm for older infant |
- Stable patients without a clear diagnosis
- No evidence-based guidelines for proper w/u / dispo decision
Disposition
Consider admission for:
- <48wk postconceptual age
- Ill-appearing
- Bronchiolitis or pertussis w/ apnea
- >1 event in past 24hr or multiple ALTEs
- Abnormalities in PMH
- Prolonged central apnea >20s
- ALTE requiring resus
- Family history of SIDS
Source
Tintinalli
